Wednesday, March 12, 2025 | 06:32 AM ISTहिंदी में पढें
Saket Misra
 "Saket Misra")
Saket Misra
Saket Misra
Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life
Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company
 "Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life")
Updated On : 18 Oct 2023 | 1:05 PM IST
Test set preference1
testing
 "Test set preference1")
Updated On : 16 Oct 2023 | 1:29 PM IST
